المؤلفون: A. V. Belopasova, P. S. Shlapakova, L. A. Dobrynina, A. S. Kadykov, А. В. Белопасова, П. С. Шлапакова, Л. А. Добрынина, А. С. Кадыков

المساهمون: The investigation has not been sponsored, Исследование не имело спонсорской поддержки

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 15, No 6 (2023); 78-84 ; Неврология, нейропсихиатрия, психосоматика; Vol 15, No 6 (2023); 78-84 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2023-6

مصطلحات موضوعية: инсульт в молодом возрасте, hereditary hemorrhagic telangiectasia, Rendu–Osler–Weber disease, pulmonary arteriovenous malformation, paradoxical embolism, stroke at a young age, наследственная геморрагическая телеангиэктазия, болезнь Рандю–Ослера–Вебера, легочная артериовенозная мальформация, парадоксальная эмболия

وصف الملف: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/2142/1609; Добрынина ЛА, Калашникова ЛА, Павлова ЛН. Ишемический инсульт в молодом возрасте. Журнал неврологии и психиатрии им. С.С. Корсакова. 2011;111(3):4-8.; Schöberl F, Ringleb PA, Wakili R, et al. Juvenile Stroke. Dtsch Arztebl Int. 2017 Aug 7;114(31-32):527-34. doi:10.3238/arztebl.2017.0527; Hart RG, Catanese L, Perera KS, et al. Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update. Stroke. 2017 Apr;48(4):867-72. doi:10.1161/STROKEAHA.116.016414. Epub 2017 Mar 6.; Кулеш АА, Демин ДА, Виноградов ОИ. Криптогенный инсульт. Часть 1: аорто-артериальная эмболия. Медицинский совет. 2021;(4):78-87. doi:10.21518/2079-701X-2021-4-78-87; Li L, Yiin GS, Geraghty OC, et al; Oxford Vascular Study. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol. 2015 Sep;14(9):903-13. doi:10.1016/S14744422(15)00132-5. Epub 2015 Jul 27.; Putaala J, Nieminen T, Haapaniemi E, et al. Undetermined stroke with an embolic pattern – a common phenotype with high early recurrence risk. Ann Med. 2015;47(5):406-13. doi:10.3109/07853890.2015.1057612. Epub 2015 Aug 4.; Faughnan ME, Mager JJ, Hetts SW, et al. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med. 2020 Dec 15;173(12):989-1001. doi:10.7326/M20-1443. Epub 2020 Sep 8.; Rendu M. Epistaxis repetes chez unsujet porteur de petits angiomies cutaneset muqueux. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris. 1886;13:731-3 (In French).; Osler W. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Johns Hopkins Med J. 1901;12:333.; Weber FP. Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages. Lancet. 1907;170:160-2.; Hanes FM. Multiple hereditary telangiectases causing hemorrhages. Bull John Hopkins Hospital. 1909;20:63-73.; Macri A, Wilson AM, Shafaat O, Sharma S. Osler-Weber-Rendu disease (hereditary hemorrhagic telangiectasia, HHT). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing LLC. 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482361/; Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-OslerWeber syndrome). Am J Med Genet. 2000 Mar 6;91(1):66-7. doi:10.1002/(sici)10968628(20000306)91:13.0.co;2-p; Faughnan ME, Palda VA, Garcia-Tsao G, et al; HHT Foundation International – Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011 Feb;48(2):73-87. doi:10.1136/jmg.2009.069013. Epub 2009 Jun 23.; Pahl KS, Choudhury A, Wusik K, et al. Applicability of the CuraНao Criteria for the Diagnosis of Hereditary Hemorrhagic Telangiectasia in the Pediatric Population. J Pediatr. 2018 Jun;197:207-13. doi:10.1016/j.jpeds.2018.01.079. Epub 2018 Apr 11.; Morgan T, McDonald J, Anderson C, et al. Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu syndrome). Pediatrics. 2002 Jan;109(1):E12. doi:10.1542/peds.109.1.e12; Schoonderwoerd MJA, Goumans MTH, Hawinkels LJAC. Endoglin: Beyond the Endothelium. Biomolecules. 2020 Feb 12;10(2):289. doi:10.3390/biom10020289; Berg J, Porteous M, Reinhardt D, et al. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet. 2003 Aug;40(8):585-90. doi:10.1136/jmg.40.8.585; Bayrak-Toydemir P, McDonald J, Markewitz B, et al. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A. 2006 Mar 1;140(5):463-70. doi:10.1002/ajmg.a.31101; McDonald J, Wooderchak-Donahue W, VanSant Webb C, et al. Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet. 2015 Jan 26;6:1. doi:10.3389/fgene.2015.00001; Halpern M, Turner AF, Citron BP. Hereditary hemorrhagic telangiectasia. An angiographic study of abdominal visceral angiodysplasias associated with gastrointestinal hemorrhage. Radiology. 1968 Jun;90(6):1143-9. doi:10.1148/90.6.1143; Dupuis-Girod S, Cottin V, Shovlin CL. The Lung in Hereditary Hemorrhagic Telangiectasia. Respiration. 2017;94(4):315-30. doi:10.1159/000479632. Epub 2017 Aug 30.; White RI Jr, Lynch-Nyhan A, Terry P, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology. 1988 Dec;169(3):663-9. doi:10.1148/radiology.169.3.3186989; Белопасова АВ, Добрынина ЛА, Калашникова ЛА и др. Легочный артериовенозный шунт – редкая причина рецидивирующих нарушений мозгового кровообращения по механизму парадоксальной эмболии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(9):107-13. doi:10.17116/jnevro2020120091107; Байдарова МД, Тупикин КА, Андрейцева ОИ. Наследственная геморагическая телеангиэктазия: современные проблемы диагностики и тактики хирургического лечения. Доказательная гастроэнтерология. 2016;(4):36-43. doi:10.17116/dokgastro20165436-43; Кулеш АА, Демин ДА, Белопасова АВ и др. Криптогенный инсульт. Часть 2: парадоксальная эмболия. Медицинский совет. 2021;(19):16-33. doi:10.21518/2079701X-2021-19-16-33; Shovlin CL, Jackson JE, Bamford KB, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax. 2008 Mar;63(3):259-66. doi:10.1136/thx.2007.087452. Epub 2007 Nov 2.; Jauss M, Zanette E. Detection of right-toleft shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis. 2000 Nov-Dec;10(6):490-6. doi:10.1159/000016119; Silvestry FE, Cohen MS, Armsby LB, et al; American Society of Echocardiography; Society for Cardiac Angiography and Interventions. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015 Aug;28(8):910-58. doi:10.1016/j.echo.2015.05.015; Чечеткин АО, Каршиева АР, Кравченко МА и др. Легочный артерио-венозный шунт как причина парадоксальной церебральной эмболии: возможности ультразвуковой диагностики. Известия Российской Военно-медицинской академии. 2019;38(3):162-4. doi:10.17816/rmmar26170; https://nnp.ima-press.net/nnp/article/view/2142

الاتاحة: https://nnp.ima-press.net/nnp/article/view/2142
https://doi.org/10.14412/2074-2711-2023-6-78-84

المؤلفون: A. Kulesh A., D. Demin A., A. Belopasova V., S. Mekhryakov A., O. Vinogradov I., L. Syromyatnikova I., A. Ziankou A., А. Кулеш А., Д. Демин А., А. Белопасова В., С. Мехряков А., О. Виноградов И., Л. Сыромятникова И., А. Зеньков А.

المصدر: Meditsinskiy sovet = Medical Council; № 19 (2021); 16-33 ; Медицинский Совет; № 19 (2021); 16-33 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: cryptogenic stroke, ESUS, paradoxical embolism, open foramen ovale, atrial septal defect, pulmonary arteriovenous malformation, криптогенный инсульт, парадоксальная эмболия, открытое овальное окно, дефект межпредсердной перегородки, легочная артериовенозная мальформация

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/6524/5909; Кулеш А.А., Сыромятникова Л.И., Дробаха В.Е., Мехряков С.А., Шестаков В.В. Криптогенный инсульт. М.: ГЭОТАР-Медиа; 2020. 128 с. https://doi.org/10.33029/9704-5597-5-CS-2020-1-128.; Кулеш А.А., Дробаха В.Е., Шестаков В.В. Криптогенный инсульт. Неврология, нейропсихиатрия, психосоматика. 2019;11(4):14–21. https://doi.org/10.14412/2074-2711-2019-4-14-21.; Ntaios G. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;75(3):333–340. https://doi.org/10.1016/j.jacc.2019.11.024.; Hart R.G., Diener H.C., Coutts S.B., Easton J.D., Granger C.B., O’Donnell M.J. et al. Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429–438. https://doi.org/10.1016/S1474-4422(13)70310-7.; Мехряков С.А., Кулеш А.А., Сыромятникова Л.И., Собянин К.В. Биомаркеры предсердной кардиопатии у пациентов с разными патогенетическими подтипами ишемического инсульта. Неврология, нейропсихиатрия, психосоматика. 2020;12(6):33–41. https://doi.org/10.14412/2074-2711-2020-6-33-41.; Кулеш А.А., Демин Д.А., Виноградов О.И. Криптогенный инсульт. Часть 1: аорто-артериальная эмболия. Медицинский совет. 2021;(4):78–87. https://doi.org/10.21518/2079-701X-2021-4-78-87.; Renna R., Pilato F., Profice P., Della Marca G., Broccolini A., Morosetti R. et al. Risk factor and etiology analysis of ischemic stroke in young adult patients. J Stroke Cerebrovasc Dis. 2014;23(3):e221-e227. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.10.008.; Кулеш А.А., Нуриева Ю.А., Сыромятникова Л.И. Причины ишемического инсульта у пациентов моложе 45 лет: анализ данных регионального сосудистого центра. Неврология, нейропсихиатрия, психосоматика. 2021;13(1):24–30. https://doi.org/10.14412/2074-2711-2021-1-24-30.; Saver J.L., Mattle H.P., Thaler D. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review. Stroke. 2018;49(6):1541–1548. https://doi.org/10.1161/STROKEAHA.117.018153.; Mojadidi M.K., Zaman M.O., Elgendy I.Y., Mahmoud A.N., Patel N.K., Agarwal N. et al. Cryptogenic Stroke and Patent Foramen Ovale. J Am Coll Cardiol. 2018;71(9):1035–1043. https://doi.org/10.1016/j.jacc.2017.12.059.; Кулеш А.А., Шестаков В.В. Открытое овальное окно и эмболический криптогенный инсульт. Неврология, нейропсихиатрия, психосоматика. 2019;11(2):4–11. https://doi.org/10.14412/2074-2711-2019-2-4-11.; Кулеш А.А., Огнерубов Д.В., Мехряков С.А., Меркулов Е.В., Сыромятникова Л.И., Терещенко А.С. и др. Инсульт, ассоциированный с открытым овальным окном: подходы к диагностике и возможности эндоваскулярной профилактики (клинические наблюдения и обзор литературы). Неврология, нейропсихиатрия, психосоматика. 2020;12(2):72–78. https://doi.org/10.14412/2074-2711-2020-2-72-78.; Geva T., Martins J.D., Wald R.M. Atrial septal defects. Lancet. 2014;383(9932):1921–1932. https://doi.org/10.1016/S0140-6736(13)62145-5.; Naqvi N., McCarthy K. P., Ho S.Y. Anatomy of the atrial septum and interatrial communications. J Thorac Dis. 2018;10(24 Suppl.):S2837-S2847. https://doi.org/10.21037/jtd.2018.02.18.; Saric M., Armour A.C., Arnaout M.S., Chaudhry F.A., Grimm R.A., Kronzon I. et al. Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism. J Am Soc Echocardiogr. 2016;29(1):1–42. https://doi.org/10.1016/j.echo.2015.09.011.; Silvestry F.E., Cohen M.S., Armsby L.B., Burkule N.J., Fleishman C.E., Hijazi Z.M. et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015;28(8):910–958. https://doi.org/10.1016/j.echo.2015.05.015.; Ewert P., Berger F., Vogel M., Dähnert I., Alexi-Meshkishvili V., Lange P.E. Morphology of perforated atrial septal aneurysm suitable for closure by transcatheter device placement. Heart. 2000;84(3):327–331. https://doi.org/10.1136/heart.84.3.327.; Nakayama M., Nawa T., Chonan T., Endo K., Morikawa S., Bando M. et al. Prevalence of Pulmonary Arteriovenous Malformations as Estimated by Low-Dose Thoracic CT Screening. Intern Med. 2012;51(13):1677–1681. https://doi.org/10.2169/internalmedicine.51.7305.; Saboo S.S., Chamarthy M., Bhalla S., Park H., Sutphin P., Kay F. et al. Pulmonary arteriovenous malformations: diagnosis. Cardiovasc Diagn Ther. 2018;8(3):325–337. https://doi.org/10.21037/cdt.2018.06.01.; Windecker S., Stortecky S., Meier B. Paradoxical embolism. J Am Coll Cardiol. 2014;64(4):403–415. https://doi.org/10.1016/j.jacc.2014.04.063.; Ozdemir A.O., Tamayo A., Munoz C., Dias B., Spence J.D. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism. J Neurol Sci. 2008;275(1-2):121–127. https://doi.org/10.1016/j.jns.2008.08.018.; Zietz A., Sutter R., De Marchis G.M. Deep Vein Thrombosis and Pulmonary Embolism Among Patients With a Cryptogenic Stroke Linked to Patent Foramen Ovale-A Review of the Literature. Front Neurol. 2020;11:336. https://doi.org/10.3389/fneur.2020.00336.; Schneider B., Hanrath P., Vogel P., Meinertz T. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol. 1990;16(4):1000–1009. https://doi.org/10.1016/s0735-1097(10)80354-7.; Мехряков С.А., Кулеш А.А., Сыромятникова Л.И. Ишемический инсульт на фоне вероятного тромбоза insitu в области аневризмы межпредсердной перегородки у пациентки, принимавшей гормональные контрацептивы. Медицинский совет. 2020;(2):132–136. https://doi.org/10.21518/2079-701X-2020-2-132-136.; Nii T., Yoshikawa H., Okabe T., Tachibana I. Septic pulmonary and systemic embolism in tricuspid endocarditis. BMJ Case Rep. 2014;2014:bcr2014206569. https://doi.org/10.1136/bcr-2014-206569.; Cramer S.C., Rordorf G., Maki J.H., Kramer L.A., Grotta J.C., Burgin W.S. et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke. 2004;35(1):46–50. https://doi.org/10.1161/01.STR.0000106137.42649.AB.; DeSimone C. V., Friedman P.A., Noheria A., Patel N.A., DeSimone D. C., Bdeir S. et al. Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale. Circulation. 2013;128(13):1433–1441. https://doi.org/10.1161/CIRCULATIONAHA.113.003540.; Moradi M., Adeli M. Brain abscess as the first manifestation of pulmonary arteriovenous malformation: A case report. Adv Biomed Res. 2014;3:28. https://doi.org/10.4103/2277-9175.124677.; Timon C., Keady C., Murphy C.G. Fat Embolism Syndrome – A Qualitative Review of its Incidence, Presentation, Pathogenesis and Management. Malays Orthop J. 2021;15(1):1–11. https://doi.org/10.5704/MOJ.2103.001; McCarthy C. J., Behravesh S., Naidu S.G., Oklu R. Air Embolism: Practical Tips for Prevention and Treatment. J Clin Med. 2016;5(11):93. https://doi.org/10.3390/jcm5110093.; Meier B., Frank B., Wahl A., Diener H.C. Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis. Eur Heart J. 2012;33(6):705–713b. https://doi.org/10.1093/eurheartj/ehr443.; Koutroulou I., Tsivgoulis G., Tsalikakis D., Karacostas D., Grigoriadis N., Karapanayiotides T. Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review. Front Neurol. 2020;11:281. https://doi.org/10.3389/fneur.2020.00281.; Alsheikh-Ali A.A., Thaler D.E., Kent D.M. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40(7):2349–2355. https://doi.org/10.1161/STROKEAHA.109.547828.; Diener H.C., Sacco R.L., Easton J.D., Granger C.B., Bernstein R.A., Uchiyama S. et al.; RE-SPECT ESUS Steering Committee and Investigators. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. N Engl J Med. 2019;380(20):1906–1917. https://doi.org/10.1056/NEJMoa1813959.; Hart R.G., Sharma M., Mundl H., Kasner S.E., Bangdiwala S.I., Berkowitz S.D. et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018;378(23):2191–2201. https://doi.org/10.1056/NEJMoa1802686.; Yetkin E., Atalay H., Ileri M. Atrial septal aneurysm: Prevalence and covariates in adults. Int J Cardiol. 2016;223:656–659. https://doi.org/10.1016/j.ijcard.2016.08.220.; Pearson A.C., Nagelhout D., Castello R., Gomez C.R., Labovitz A.J. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol. 1991;18(5):1223–1229. https://doi.org/10.1016/0735-1097(91)90539-l.; Agmon Y., Khandheria B.K., Meissner I., Gentile F., Whisnant J.P., Sicks J.D. et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation. 1999;99(15):1942–1944. https://doi.org/10.1161/01.cir.99.15.1942.; Cabanes L., Mas J.L., Cohen A., Amarenco P., Cabanes P.A., Oubary P. et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke. 1993;24(12):1865–1873. https://doi.org/10.1161/01.str.24.12.1865.; Elgendy A.Y., Saver J.L., Amin Z., Boudoulas K.D., Carroll J.D., Elgendy I.Y. et al. Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. AMA Neurol. 2020;77(7):878–886. https://doi.org/10.1001/jamaneurol.2020.0458.; Мехряков C.А., Кулеш А.А., Покаленко Е.А., Сыромятникова Л.И., Куликова С.П., Дробаха В.Е. и др. Феномен парадоксальной эмболии у пациентов с эмболическим криптогенным инсультом. Неврология, нейропсихиатрия, психосоматика. 2020;12(1):13–21. https://doi.org/10.14412/2074-2711-2020-1-13-21.; Ioannidis S.G., Mitsias P.D. Patent Foramen Ovale in Cryptogenic Ischemic Stroke: Direct Cause, Risk Factor, or Incidental Finding? Front Neurol. 2020;11:567. https://doi.org/10.3389/fneur.2020.00567.; Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900. https://doi.org/10.1016/s0735-1097(02)01886-7.; Lindsey J.B., Hillis L.D. Clinical update: atrial septal defects in adults. Lancet. 2007;369(9569):1244–1246. https://doi.org/10.1016/S0140-6736(07)60576-5.; Mügge A., Daniel W.G., Angermann C., Spes C., Khandheria B.K., Kronzon I. et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995;91(11):2785–2792. https://doi.org/10.1161/01.cir.91.11.2785.; Bannan A., Shen R., Silvestry F.E., Herrmann H.C. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism. Catheter Cardiovasc Interv. 2009;74(7):1066–1069. https://doi.org/10.1002/ccd.22170.; Leppert M., Poisson S.N., Carroll J.D. Atrial Septal Defects and Cardioembolic Strokes. Cardiol Clin. 2016;34(2):225–230. https://doi.org/10.1016/j.ccl.2015.12.004.; Gatzoulis M.A., Freeman M.A., Siu S.C., Webb G.D., Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340(11):839–846. https://doi.org/10.1056/NEJM199903183401103.; Berger F., Vogel M., Kramer A., Alexi-Meskishvili V., Weng Y., Lange P.E., Hetzer R. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg. 1999;68(1): 75–78. https://doi.org/10.1016/s0003-4975(99)00478-6.; Diller G.P., Gatzoulis M.A. Pulmonary vascular disease in adults with congenital heart disease. Circulation. 2007;115(8):1039–1050. https://doi.org/10.1161/CIRCULATIONAHA.105.592386.; Cottin V., Chinet T., Lavolé A., Corre R., Marchand E., Reynaud-Gaubert M. et al. Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia. Medicine (Baltimore). 2007;86(1):1–17. https://doi.org/10.1097/MD.0b013e31802f8da1.; Contegiacomo A., Del Ciello A., Rella R., Attempati N., Coppolino D., Larici A.R. et al. Pulmonary arteriovenous malformations: what the interventional radiologist needs to know. Radiol Med. 2019;124(10): 973–988. https://doi.org/10.1007/s11547-019-01051-7.; Elmali M., Akan H., Findik S., Kale M., Celenk C. Hereditary Hemorrhagic Telangiectasia Associated With Pulmonary Arteriovenous Malformations Presenting as Hemothorax. J Thorac Imaging. 2008;23(4):295–297 https://doi.org/10.1097/RTI.0b013e3181820867.; Hoeper M.M., Krowka M.J., Strassburg C.P. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004;363(9419):1461–1468. https://doi.org/10.1016/S0140-6736(04)16107-2.; Wong H.H., Chan R.P., Klatt R., Faughnan M.E. Idiopathic pulmonary arteriovenous malformations: clinical and imaging characteristics. Eur Respir J. 2011;38(2):368–375. https://doi.org/10.1183/09031936.00075110.; Bosher L.H. Jr, Blake D.A., Byrd B.R. An analysis of the pathologic anatomy of pulmonary arteriovenous aneurysms with particular reference to the applicability of local excision. Surgery. 1959;45(1): 91–104. Available at: https://pubmed.ncbi.nlm.nih.gov/13624986.; Vorselaars V.M., Velthuis S., Snijder R.J., Westermann C.J., Vos J.A., Mager J.J., Post M.C. Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia. Eur Respir J. 2016;47(6): 1750–1757. https://doi.org/10.1183/13993003.01588-2015.; Horner S., Niederkorn K., Gattringer T., Furtner M., Topakian R, Lang W. et al. Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry. J Neurol. 2013;260(1):260–267. https://doi.org/10.1007/s00415-012-6629-9.; Topiwala K.K., Patel S.D., Pervez M., Shovlin C.L., Alberts M.J. Ischemic Stroke in Patients With Pulmonary Arteriovenous Fistulas. Stroke. 2021;52(7):e311-e315. https://doi.org/10.1161/STROKEAHA.120.032073.; Velthuis S., Buscarini E., van Gent M.W. F., Gazzaniga P., Manfredi G., Danesino C. et al. Grade of pulmonary right-to-left shunt on contrast echocardiography and cerebral complications: a striking association. Chest. 2013;144(2):542–548. https://doi.org/10.1378/chest.12-1599.; Pareés I., Horga A., Santamarina E., Mendióroz M., Fernández-Cádenas I., del Río-Espínola A., Alvarez-Sabín J. Stroke after prolonged air travel associated with a pulmonary arteriovenous malformation. J Neurol Sci. 2010;292(1-2):99–100. https://doi.org/10.1016/j.jns.2010.02.019.; Yassi N., Yan B., Dowling R., Mitchell P.J. A rare cause of embolic stroke in hereditary hemorrhagic telangiectasia. J Stroke Cerebrovasc Dis. 2014;23(5):1245–1246. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.07.037.; Zanati Bazan S.G., Braga G.P., Luvizutto G.J., Trindade A.P., PontesNeto O.M., Bazan R. Bihemispheric Paradoxical Cerebral Embolism in a Patient with Pulmonary Thromboembolism and Presumptive Fistula Right-to-Left Shunt. J Stroke Cerebrovasc Dis. 2016;25(6):e95-e97. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.03.038.; Ng P.Y., Ng A.K., Subramaniam B., Burns S.M., Herisson F., Timm F.P. et al. Association of Preoperatively Diagnosed Patent Foramen Ovale With Perioperative Ischemic Stroke. JAMA. 2018;319(5):452–462. https://doi.org/10.1001/jama.2017.21899.; Snijder R.J., Luermans J.G., de Heij A.H., Thijs V., Schonewille W.J., Van De Bruaene A, Swaans M.J. et al. Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study. J Am Heart Assoc. 2016;5(12):e003771. https://doi.org/10.1161/JAHA.116.003771.; West B.H., Noureddin N., Mamzhi Y., Low C.G., Coluzzi A.C., Shih E.J. et al. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke. Stroke. 2018;49(5):1123–1128. https://doi.org/10.1161/STROKEAHA.117.020160.; Guchlerner M., Kardos P., Liss-Koch E., Franke J., Wunderlich N., Bertog S., Sievert H. PFO and right-to-left shunting in patients with obstructive sleep apnea. J Clin Sleep Med. 2012;8(4):375–380. https://doi.org/10.5664/jcsm.2026.; Faughnan M.E., Mager J.J., Hetts S.W., Palda V.A., Lang-Robertson K., Buscarini E. et al. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med. 2020;173(12):989–1001. https://doi.org/10.7326/M20-1443.; Shovlin C.L., Guttmacher A.E., Buscarini E., Faughnan M.E., Hyland R.H., Westermann C.J. et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91(1):66–67. https://doi.org/10.1002/(sici)1096-8628(20000306)91:13.0.co;2-p.; Holden V.K., Shah N.G., Verceles A.C. Implications of an Incidental Pulmonary Arteriovenous Malformation. J Investig Med High Impact Case Rep. 2016;4(1):2324709616637190. https://doi.org/10.1177/2324709616637190.; Santamarina E., González-Alujas M.T., Muñoz V., Rovira A., Rubiera M., Ribó M. et al. Stroke patients with cardiac atrial septal abnormalities: differential infarct patterns on DWI. J Neuroimaging. 2006;16(4):334–340. https://doi.org/10.1111/j.1552-6569.2006.00056.x.; Nam K.W., Guk H.S., Kwon H.M., Lee Y.S. Diffusion-Weighted Imaging Patterns According to the Right-to-Left Shunt Amount in Cryptogenic Stroke. Cerebrovasc Dis. 2019;48(1-2):45–52. https://doi.org/10.1159/000502882.; Jauss M., Wessels T., Trittmacher S., Allendörfer J., Kaps M. Embolic lesion pattern in stroke patients with patent foramen ovale compared with patients lacking an embolic source. Stroke. 2006;37(8):2159–2161. https://doi.org/10.1161/01.STR.0000231645.22128.ab.; Hayashida K., Fukuchi K., Inubushi M., Fukushima K., Imakita S., Kimura K. Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography. J Nucl Med. 2001;42(6):859–863. https://jnm.snmjournals.org/content/42/6/859.long.; Kim J.W., Kim S.J., Yoon C.W., Park C.H., Kang K.W., Kim S.K. et al. Association between the amount of right-to-left shunt and infarct patterns in patients with cryptogenic embolic stroke: a transcranial Doppler study. Int J Stroke. 2013;8(8):657–662. https://doi.org/10.1111/j.1747-4949.2012.00846.x.; Mahmoud A.N., Elgendy I.Y., Agarwal N., Tobis J.M., Mojadidi M.K. Identification and quantification of patent foramen ovale mediated shunts: echocardiography and transcranial Doppler. Interv Cardiol Clin. 2017;6(4):495–504. https://doi.org/10.1016/j.iccl.2017.05.002.; Gutgesell H.P., Huhta J.C., Latson L.A., Huffines D., McNamara D.G. Accuracy of two-dimensional echocardiography in the diagnosis of congenital heart disease. Am J Cardiol. 1985;55(5):514–518. https://doi.org/10.1016/0002-9149(85)90237-1.; Cakmak S., Goldman C., Bozio A., Nighoghossian N., Derex L., Trouillas P. Sinus venosus-type atrial septal defect: a rare curable cause of recurrent transient neurological deficits. Stroke. 2006;37(9):2385–2386. https://doi.org/10.1161/01.STR.0000236635.44539.d4.; Mojadidi M.K., Gevorgyan R., Tobis J.M. A comparison of methods to detect and quantitate PFO: TCD, TTE, ICE and TEE. In: Amin Z., Tobis J.M., Sievert H., Carroll J. (eds.). Patent Foramen Ovale. London: Springer; 2015. pp. 55-65. https://dx.doi.org/10.1007/978-1-4471-4987-3_7.; Mojadidi M.K., Zhang L., Chugh Y., Eshtehardi P., Hovnanians N., Gevorgyan R. et al. Transcranial Doppler: does addition of blood to agitated saline affect sensitivity for detecting cardiac right-to-left shunt? Echocardiography. 2016;33(8):1219–1227. https://doi.org/10.1111/echo.13231.; Fan S., Nagai T., Luo H., Atar S., Naqvi T., Birnbaum Y. et al. Superiority of the combination of blood and agitated saline for routine contrast enhancement. J Am Soc Echocardiogr. 1999;12:94–98. https://doi.org/10.1016/s0894-7317(99)70120-3.; Sun Y.P., Homma S. Patent Foramen Ovale and Stroke. Circ J. 2016;80(8):1665–1673. https://doi.org/10.1253/circj.CJ-16-0534.; Bang O.Y., Lee M.J., Ryoo S., Kim S.J., Kim J.W. Patent Foramen Ovale and Stroke-Current Status. J Stroke. 2015;17(3):229–237. https://doi.org/10.5853/jos.2015.17.3.229.; Porter T.R., Abdelmoneim S., Belcik J.T., McCulloch M. L., Mulvagh S.L., Olson J.J. et al. Guidelines for the Cardiac Sonographer in the Performance of Contrast Echocardiography: A Focused Update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2014;27(8):794–810. https://doi.org/10.1016/j.echo.2014.05.011.; Katsanos A.H., Psaltopoulou T., Sergentanis T.N., Frogoudaki A., Vrettou A.R., Ikonomidis I. et al. Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta-analysis. Ann Neurol. 2016;79(4):625–635. https://doi.org/10.1002/ana.24609.; Droste D.W., Lakemeier S., Wichter T., Stypmann J., Dittrich R., Ritter M. et al. Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Stroke. 2002;33(9):2211–2216. https://doi.org/10.1161/01.str.0000027884.03365.ac.; Hoksbergen A.W., Legemate D.A., Ubbink D.T., Jacobs M.J. Success rate of transcranial color-coded duplex ultrasonography in visualizing the basal cerebral arteries in vascular patients over 60 years of age. Stroke. 1999;30(7):1450–1455. https://doi.org/10.1161/01.str.30.7.1450.; Del Sette M., Dinia L., Rizzi D., Sugo A., Albano B., Gandolfo C. Diagnosis of Right-to-Left Shunt With Transcranial Doppler and Vertebrobasilar Recording; Stroke. 2007;38(8):2254–2256. https://doi.org/10.1161/STROKEAHA.106.479485.; Serena J., Segura T., Perez-Ayuso M.J. Bassaganyas J., Molins A., Dávalos A. The need to quantify right-to-left shunt in acute ischemic stroke: A case-control study. Stroke. 1998;29(7):1322–1328. https://doi.org/10.1161/01.str.29.7.1322.; Белопасова А.В., Добрынина Л.А., Калашникова Л.А., Чечеткин А.О., Каршиева А.Р., Абугов С.А. и др. Легочный артериовенозный шунт – причина рецидивирующих нарушений мозгового кровообращения по механизму парадоксальной эмболии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(9):107–113. https://doi.org/10.17116/jnevro2020120091107.; Majumdar Sh., McWilliams J.P. Approach to pulmonary arteriovenous malformation: A comprehensive update. J Clin Med. 2020;9(6):1927. https://doi.org/10.3390/jcm9061927.; Чечеткин А.О., Каршиева А.Р., Кравченко М.А., Белопасова А.В., Калашникова Л.А., Добрынина Л.А. Легочный артерио-венозный шунт как причина парадоксальной церебральной эмболии: возможности ультразвуковой диагностики. Вестник Российской Военно-медицинской академии. 2019;(S3):162–164. https://doi.org/10.32863/1682-7392-2019-3-67-162-164.; Pristipino C., Sievert H., D’Ascenzo F., Louis Mas J., Meier B., Scacciatella P. et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019;40(38):3182–3195. https://doi.org/10.1093/eurheartj/ehy649.; Le Moigne E., Timsit S., Ben Salem D., Didier R., Jobic Y., Paleiron N. et al. Patent Foramen Ovale and Ischemic Stroke in Patients With Pulmonary Embolism: A Prospective Cohort Study. Ann Intern Med. 2019;170(11):756–763. https://doi.org/10.7326/M18-3485.; Kim Y.D., Song D., Nam H.S., Lee K., Yoo J., Hong G.R. et al. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale. Thromb Haemost. 2015;114(3):614–622. https://doi.org/10.1160/TH14-12-1040.; Liu K., Song B., Palacios I.F., Inglessis-Azuaje I., Deng W., McMullin D. et al. Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure. JACC Cardiovasc Interv. 2020;13(23):2745–2752. https://doi.org/10.1016/j.jcin.2020.09.059.; Salehi Omran S., Hartman A., Zakai N.A., Navi B.B. Thrombophilia Testing After Ischemic Stroke: Why, When, and What?. Stroke. 2021;52(5):1874–1884. https://doi.org/10.1161/STROKEAHA.120.032360.; Deng W., McMullin D., Inglessis-Azuaje I., Locascio J.J., Palacios I.F., Buonanno F.S. et al. Effect of Patent Foramen Ovale Closure After Stroke on Circulatory Biomarkers. Neurology. 2021;97(2):e203-e214. https://doi.org/10.1212/WNL.0000000000012188.; Kent D.M., Saver J.L., Ruthazer R., Furlan A.J., Reisman M., Carroll J.D. et al. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials. Stroke. 2020;51(10):3119–3123. https://doi.org/10.1161/STROKEAHA.120.029350.; Nakayama R., Takaya Y., Akagi T., Watanabe N., Ikeda M., Nakagawa K. et al. Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke: Development of a Scoring System. J Am Soc Echocardiogr. 2019;32(7):811–816. https://doi.org/10.1016/j.echo.2019.03.021.; Elgendy A.Y., Elgendy I.Y., Mojadidi M.K., Mahmoud A.N., Barry J.S., Jneid H. et al. New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials. EuroIntervention. 2019;14(17):1788–1790. https://doi.org/10.4244/eij-d-18-00767.; Varotto L., Bregolin G., Paccanaro M., De Boni A., Bonanno C., Perini F. Network meta-analysis on patent foramen ovale: is a stroke or atrial fibrillation worse?. Neurol Sci. 2021;42(1):101–109. https://doi.org/10.1007/s10072-020-04922-4.; Огнерубов Д.В., Терещенко А.С., Самко А.Н., Арутюнян Г.К., Сивакова О.А., Певзнер Д.В. и др. Безопасность и эффективность эндоваскулярного закрытия открытого овального окна: первые результаты российского многоцентрового исследования. Неврология, нейропсихиатрия, психосоматика. 2020;12(6):26–32. https://doi.org/10.14412/2074-2711-2020-6-26-32.; Wintzer-Wehekind J., Alperi A., Houde C., Côté J.M., Asmarats L., Côté M., Rodés-Cabau J. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism. J Am Coll Cardiol. 2019;73(3):278–287. https://doi.org/10.1016/j.jacc.2018.10.061.; Deng W., Yin S., McMullin D., Inglessis-Azuaje I., Elmariah S., Hung J. et al. Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study. Ann Intern Med. 2020;172(11):717–725. https://doi.org/10.7326/M19-3583.; Hoffmann A., Chockalingam P., Balint O.H., Dadashev A., Dimopoulos K., Engel R. et al. Cerebrovascular accidents in adult patients with congenital heart disease. Heart. 2010;96:1223–1226. https://doi.org/10.1136/hrt.2010.196147.; Nyboe C., Olsen M.S., Nielsen-Kudsk J.E., Hjortdal V.E. Atrial fibrillation and stroke in adult patients with atrial septal defect and long-term effect of closure. Heart. 2015;101:706–711. https://doi.org/10.1136/heartjnl-2014-306552.; Angelini F., Fortuni F., Tsivgoulis G., Agnelli G., Bocchino P.P., Franchin L. et al. Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis. Cardiovasc Drugs Ther. 2021;35(5):987–993. https://doi.org/10.1007/s10557-020-07068-9.; Бобров Е.И. Артериовенозные фистулы лёгких: диагностика и эндоваскулярное лечение. Региональное кровообращение и микроциркуляция. 2003;2(3):11–16. Режим доступа: https://elibrary.ru/item.asp?id=13074540.; Pereira-da-Silva T., Martins J.D., de Sousa L., Fiarresga A., Trigo Pereira C., Cruz Ferreira R., Ferreira Pinto F. Percutaneous occlusion of vascular malformations in pediatric and adult patients: 20-year experience of a single center. Catheter Cardiovasc Interv. 2016;87(2):E62-E68. https://doi.org/10.1002/ccd.26220.; Noble S., Perren F., Roffi M. Cryptogenic stroke with right-to-left shunt and no patent foramen ovale. Arch Cardiovasc Dis. 2014;107(6-7):418–419. https://doi.org/10.1016/j.acvd.2012.07.004.; Barbaryan A., Bailuc S., Raqeem M.W., Kak M., Derani L., Mirrakhimov A.E. Wake-Up Call: Pulmonary Arteriovenous Malformation. Am J Med. 2017;130(3):290–292. https://doi.org/10.1016/j.amjmed.2016.10.021.; Patti G., D’Antonio L., Sedati P., Mega S., Di Sciascio G. Percutaneous closure of a pulmonary arteriovenous malformation in young patient with cryptogenic stroke. JACC CardiovascInterv. 2013;6(5):e26-e27. https://doi.org/10.1016/j.jcin.2012.11.016.; Ishikawa Y., Yamanaka K., Nishii T., Fujii K., Rino Y., Maehara T. Videoassisted thoracoscopic surgery for pulmonary arteriovenous malformations: report of five cases. Gen Thorac Cardiovasc Surg. 2008;56(4):187–190. https://doi.org/10.1007/s11748-007-0215-6.; Nakamura H., Miwa K., Haruki T., Adachi Y., Fujioka S., Taniguchi Y. Pulmonary arteriovenous fistula with cerebral infarction successfully treated by video-assisted thoracic surgery. Ann Thorac Cardiovasc Surg. 2008;14(1):35–37. Available at: https://pubmed.ncbi.nlm.nih.gov/18292739/; Faughnan M., Palda V., Garcia-Tsao G., Geisthoff U., McDonald J., Proctor D. et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48:73–87. https://doi.org/10.1136/jmg.2009.069013.; Devlin H.L., Hosman A.E., Shovlin C.L. Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia. N Engl J Med. 2013;368(9):876–878. https://doi.org/10.1056/NEJMc1213554.; Shovlin C.L., Millar C.M., Droege F., Kjeldsen A., Manfredi G., Suppressa P. et al. Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2019;14(1):210. https://doi.org/10.1186/s13023-019-1179-1.; Kleindorfer D.O., Towfighi A., Chaturvedi S., Cockroft K.M., Gutierrez J., Lombardi-Hill D. et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association / American Stroke Association. Stroke. 2021;52(7):e364-e467. https://doi.org/10.1161/STR.0000000000000375.; Baumgartner H., De Backer J., Babu-Narayan S.V., Budts W., Chessa M., Diller G.P. et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563–645. https://doi.org/10.1093/eurheartj/ehaa554.; Shovlin C.L., Condliffe R., Donaldson J.W., Kiely D.G., Wort S.J. British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations. Thorax. 2017;72(12):1154–1163. https://doi.org/10.1136/thoraxjnl-2017-210764.; https://www.med-sovet.pro/jour/article/view/6524

الاتاحة: https://www.med-sovet.pro/jour/article/view/6524
https://doi.org/10.21518/2079-701X-2021-19-16-33

المؤلفون: Linnik, O. V., Sidorovich, E. K., Likhachev, S. A., Chernukha, T. N., Linnik, Yu. I., Shevchenko, N. S., Линник, О. В., Сидорович, Э. К., Лихачев, С. А., Чернуха, Т. Н., Линник, Ю. И., Шевченко, Н. С.

مصطلحات موضوعية: RENDU-OSLER-WEBER DISEASE, PULMONARY ARTERIOVENOUS MALFORMATION, STROKE, CLINICAL CASE, EMBOLOTHERAPY, БОЛЕЗНЬ РАНДЮ-ОСЛЕРА-ВЕБЕРА, ЛЕГОЧНАЯ АРТЕРИОВЕНОЗНАЯ МАЛЬФОРМАЦИЯ, ИНФАРКТ МОЗГА, КЛИНИЧЕСКИЙ СЛУЧАЙ, ЭМБОЛОТЕРАПИЯ

وصف الملف: application/pdf

Relation: Уральский медицинский журнал. 2018. Т. 166, № 11.; Клинический случай повторных инфарктов головного мозга у пациента молодого возраста с болезнью Рандю-Ослера-Вебера / О. В. Линник, Э. К. Сидорович, С. А. Лихачев [и др.]. – Текст: электронный // Уральский медицинский журнал. - 2018. – T. 166, № 11. – С. 46-52.; http://elib.usma.ru/handle/usma/12906

الاتاحة: http://elib.usma.ru/handle/usma/12906

مصطلحات موضوعية: pulmonary arteriovenous malformation, embolotherapy, clinical case, легочная артериовенозная мальформация, эмболотерапия, болезнь Рандю-Ослера-Вебера, инфаркт мозга, клинический случай, Rendu-Osler-Weber disease, stroke

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5ae4b3ec419c3abf7d4aee13db1d2cac

مصطلحات موضوعية: pulmonary arteriovenous malformation, congenital heart defect, врожденный порок сердца, occlusion of pulmonary arteriovenous malformation in newborn, легочная артериовенозная мальформация, окклюдер, occluder, окклюзия АВМ легкого у новорожденного

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9299a5a059d631fff498cde3151eb538